van Breemen Richard B, Fong Harry Hs, Farnsworth Norman R
University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, L 60612, USA.
Am J Clin Nutr. 2008 Feb;87(2):509S-13S. doi: 10.1093/ajcn/87.2.509S.
Botanical dietary supplements with a history of safe human use may not require the same level of toxicity testing as synthetic pharmaceutical drugs. Most of the documented examples of acute toxicity caused by botanical dietary supplements have been caused by the substitution of toxic plants for the desired species, probably through misidentification or production errors, or by contamination with pharmaceutical agents, either as a result of poor manufacturing practices or adulteration. Although more difficult to document, chronic toxicities attributed to botanical dietary supplements may be caused by contamination by heavy metals, pesticides, or microbes or by inherent properties of constituents of the botanicals themselves. Like drug-drug interactions, botanical-drug interactions can also be a source of toxicity. Most of these toxicity problems may be prevented by implementing good agricultural practices and good manufacturing practices and applying existing toxicity testing similar to those used in drug development or new toxicity assays under development based on proteomics, genomics, or metabolomics.
有着安全的人类使用历史的植物性膳食补充剂可能不需要与合成药物相同水平的毒性测试。植物性膳食补充剂导致急性毒性的大多数已记录案例是由有毒植物替代所需物种造成的,这可能是由于误认或生产错误,或者是由于不良生产规范或掺假导致的药物制剂污染。虽然更难记录,但归因于植物性膳食补充剂的慢性毒性可能是由重金属、农药或微生物污染或植物成分本身的固有特性引起的。与药物相互作用一样,植物与药物的相互作用也可能是毒性的一个来源。通过实施良好农业规范和良好生产规范,并应用类似于药物开发中使用的现有毒性测试或基于蛋白质组学、基因组学或代谢组学正在开发的新毒性测定方法,大多数这些毒性问题是可以预防的。